首页> 外文期刊>BMC Nephrology >Chronic kidney disease in the Top End of the Northern Territory of Australia, 2002–2011: a retrospective cohort study using existing laboratory data
【24h】

Chronic kidney disease in the Top End of the Northern Territory of Australia, 2002–2011: a retrospective cohort study using existing laboratory data

机译:慢性肾病在澳大利亚北领地的顶端,2002-2011:使用现有实验室数据的回顾性队列研究

获取原文
           

摘要

Background The Northern Territory of Australia has a very high incidence of treated end-stage kidney disease (ESKD), largely confined to Indigenous Australians living in remote, under-resourced areas. Surveillance of chronic kidney disease (CKD) is still in its infancy in Australia. We estimate the prevalence and rate of progression of measured CKD across a region using inexpensive readily available laboratory information. Methods Using a retrospective de-identified extraction of all records with a serum creatinine or urinary albumin-to-creatinine ratio from the single largest ambulatory pathology provider to the Top End of the Northern Territory of Australia between 1st February 2002 and 31st December 2011, the yearly total and age-specific prevalence of measured microalbuminuria, overt albuminuria and estimated glomerular filtration rate (eGFR) 2 , and the prevalence of progressive CKD, were calculated. Results There was a steady increase in the proportion tested across all health districts in the region, more prominent in non-urban districts. In 2009, the regional adult prevalence of measured microalbuminuria and overt albuminuria was as high as 8.1?%, overt albuminuria alone up to 3.0?% and eGFR??300?mg/mmol). Conclusions The rates of testing, particularly in districts of high measured prevalence of markers of CKD, are encouraging. However, extremely high rates of progressive CKD are troubling. Further describing the outcomes of CKD in this population would require analysis of linked datasets.
机译:背景技术澳大利亚北部境内具有非常高的治疗终末期肾病(ESKD)的发病率,主要被限制在遥远,资源不足的地区的土着澳大利亚人。慢性肾病(CKD)监测仍处于澳大利亚的婴儿期。我们估计使用廉价的容易获得的实验室信息,估计在区域中测量CKD的进展率。方法使用血清肌酐或尿白霉素与群体比例的回顾性解除鉴定的所有记录从单一最大的动态病理提供者到2002年2月1日至2011年12月31日之间的澳大利亚北领地的顶端。计算了测量的微蛋氨酸,公开白蛋白尿和估计的肾小球过滤速率(EGFR)2 的年龄和年龄特异性患病率,以及进行性CKD的患病率。结果该地区所有健康区测试的比例稳步增加,在非城市地区更加突出。 2009年,测量的微蛋氨酸和公开白蛋白尿的区域成年患病率高达8.1μm,优异的白蛋白尿,最明显的白蛋白尿,高达3.0?%和EGFR ?? Mg / mmol)。结论测试率,特别是在CKD标记的高度测量的地区,是令人鼓舞的。然而,极高的进步CKD率是令人不安的。进一步描述该群体中CKD的结果需要分析链接数据集。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号